Dr. Khan brings decades of global medical affairs, commercial, and scientific leadership across multiple therapeutic areas including seven successful product launchesCAMBRIDGE, Mass., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company dedicated to transforming the treatment of autoimmune diseases, today announced the appointment of Navid Z. Khan, Ph.D., as Chief Medical Affairs Officer. Dr. Khan joins Vor Bio with over two decades of experience spanning medical ...

  TORONTO and BOSTON - September 22, 2025 - TheNewswire — Sernova Biotherapeutics (“Sernova”) (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH) a leading regenerative medicine company focused on developing its Cell Pouch Bio-hybrid Organ as a functional cure for type 1 diabetes (T1D), today announced the appointment of John L. Brooks III as Chair of the Company’s Board of Directors.  “We are honored to have John lead our Board at this exciting time for Sernova,” said Jonathan Rigby, CEO of Sernova. “His deep expe ...

MIAMI and TURKU, Finland , Sept. 23, 2025 /PRNewswire/ --Â Royal Caribbean Group (NYSE:Â RCL), a global vacation leader that is redefining the future of vacations, today announced a long-term framework agreement with Meyer Turku that secures Royal Caribbean Group's rights to build at the yard through the next decade. ...

Vancouver, British Columbia--(Newsfile Corp. - September 23, 2025) - Inverite Insights Inc.  (CSE: INVR) (OTC Pink: INVRD) (FSE: 2V0) ("Inverite") a leading AI-driven software provider utilizing real-time financial data to empower businesses to transact more effectively with consumers, is pleased to announce that its Chief Executive Officer, Karim Nanji, has been appointed to the Board of Directors of the Financial Data and Technology Association ("FDATA").FDATA is a global industry body dedicated to promo ...

SALT LAKE CITY and BOSTON, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics (Nasdaq: MYGN), a leader in molecular diagnostic testing and precision medicine, and SOPHiA GENETICS (Nasdaq: SOPH), an AI technology company transforming precision medicine, announced a strategic collaboration to develop and provide pharmaceutical companies with an innovative global liquid biopsy companion diagnostic (CDx) test. This partnership will leverage Myriad’s advanced laboratory capabilities in the U.S. to support global ...

RED BANK, N.J. , Sept. 23, 2025 /PRNewswire/ -- PAX Health, a leading behavioral healthcare company backed by HCAP Partners and funds managed by Hamilton Lane (Nasdaq:HLNE), today announced its acquisition of Neuropsychology and Counseling Associates, a comprehensive outpatient mental health practice serving children, adolescents, adults, and families throughout New Jersey. ...

COVID-19 TESTING LABORATORY SUBSIDIARIES FILE FOR BANKRUPCTY PROTECTION UNIONDALE, NY, Sept. 23, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next generation biotech, genomics and consumer products company, announced that its three COVID-19 testing laboratory companies filed for reorganization under Chapter 11 in United States Bankruptcy Court for the District of New Jersey, advancing the Crown Medical Collections initiative to the key next step. This bankrupt ...

With a focus on REITs, ETFs, Preferreds, and 'Dividend Champions' across asset classes, members gain complete access to our research and our suite of trackers and portfolios targeting premium dividend yields up to 10%.iREIT®+HOYA Capital is the premier income-focused investing service on Seeking Alpha. Our focus is on income-producing asset classes that offer the opportunity for sustainable portfolio income, diversification, and inflation hedging. Get started with a Free Two-Week Trial and take a look at ou ...

OFA proudly announces the launch of QikBIM, in collaboration with Alan To AI Consultancy Co., now open for registration and pilot testing by architectural design firms worldwide. This leap forward is expected to reduce the time and labor costs of architectural design, establishing a new benchmark for efficiency and innovation in the industry. Los Angeles, CA, Sept. 23, 2025 (GLOBE NEWSWIRE) -- OFA Group (Nasdaq: OFAL) (“OFA” or “the Company”), a leader in AI-driven architectural technologies, today announce ...

BRISTOL, Tenn., Sept. 23, 2025 (GLOBE NEWSWIRE) -- VanderbiltReport.com, a financial news and content platform, reports that Coeptis Therapeutics (NASDAQ: COEP) is pioneering a dual-track model designed to sustain innovation while reducing reliance on dilutive funding. The biotech industry is known for high burn rates and long timelines. Companies often face an impossible choice between continuous capital raises or scaling back scientific ambitions. Coeptis is demonstrating that hybrid business models can p ...